Definitive Healthcare (NASDAQ:DH) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Definitive Healthcare Corp. (NASDAQ:DH)’s stock price passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $1.11 and traded as high as $1.15. Definitive Healthcare shares last traded at $1.14, with a volume of 472,430 shares.

Wall Street Analyst Weigh In

DH has been the topic of a number of recent research reports. Morgan Stanley decreased their price objective on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Definitive Healthcare in a research note on Monday, August 31st. Wall Street Zen raised Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, September 13th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $1.00 target price on shares of Definitive Healthcare in a research report on Wednesday, August 12th. Finally, BTIG Research restated a “neutral” rating on shares of Definitive Healthcare in a research report on Friday, September 4th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of “Reduce” and a consensus target price of $1.47.

Definitive Healthcare Stock Performance

The firm has a market cap of $119.56 million, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 13.82 and a beta of 1.40. The company has a current ratio of 1.86, a quick ratio of 1.86 and a debt-to-equity ratio of 0.81. The company’s fifty day moving average price is $0.98 and its two-hundred day moving average price is $1.09.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. The firm had revenue of $55.20 million during the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, sell-side analysts predict that Definitive Healthcare Corp. will post 0.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Definitive Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of DH. Corient Private Wealth LP acquired a new position in Definitive Healthcare during the 2nd quarter worth about $378,000. Squarepoint Ops LLC increased its position in Definitive Healthcare by 46.5% in the 2nd quarter. Squarepoint Ops LLC now owns 351,575 shares of the company’s stock valued at $292,000 after acquiring an additional 111,634 shares in the last quarter. Williams & Novak Wealth Management LLC raised its stake in shares of Definitive Healthcare by 15.3% in the third quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company’s stock worth $82,000 after acquiring an additional 12,000 shares during the last quarter. Irenic Capital Management LP bought a new position in shares of Definitive Healthcare in the first quarter worth about $71,000. Finally, Williams & Novak LLC lifted its position in shares of Definitive Healthcare by 155.8% during the second quarter. Williams & Novak LLC now owns 78,610 shares of the company’s stock worth $65,000 after purchasing an additional 47,880 shares in the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.